Skip to main content
Clinical Trials/DRKS00032584
DRKS00032584
Completed
Not Applicable

Validation of non-radiative MRI-based multi-atlas attenuation correction for single-photon emission computed tomography - MRI-based attenuation correction for SPECT

niklinik Köln, Klinik für Nuklearmedizin0 sites12 target enrollmentSeptember 26, 2023
ConditionsG20.0

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G20.0
Sponsor
niklinik Köln, Klinik für Nuklearmedizin
Enrollment
12
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2023
End Date
February 8, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niklinik Köln, Klinik für Nuklearmedizin

Eligibility Criteria

Inclusion Criteria

  • 1\.Parkinson’s Disease (Hoehn and Yahr \<3\)
  • 2\.Participant of the DoMoCo study who previously gave consent that they can be contacted in the future for scientific purpose
  • 3\.DAT\-SPECT at the Department of Nuclear Medicine for diagnostic purpose
  • 4\.Compatible MRI as part of DoMoCo study
  • 5\.Written informed consent

Exclusion Criteria

  • 1\.Any radiation exposure in the recent 10 years for scientific or therapy purposes
  • 2\.Pregnancy/breast feeding
  • 3\.Severe physical illness/physical conditions
  • 4\.Claustrophobia or excessive overweight

Outcomes

Primary Outcomes

Not specified

Similar Trials